Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Account Payables (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Change in Account Payables for 6 consecutive years, with -$3891.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 1660.63% to -$3891.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1952.0 through Dec 2025, down 454.26% year-over-year, with the annual reading at -$1952.0 for FY2025, 454.26% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$3891.0 at BioScience Health Innovations, up from -$6471.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $8189.0 in Q1 2025, with the low at -$14334.0 in Q2 2023.
  • Average Change in Account Payables over 5 years is -$153.25, with a median of $728.5 recorded in 2021.
  • Peak annual rise in Change in Account Payables hit 337.91% in 2025, while the deepest fall reached 1660.63% in 2025.
  • Over 5 years, Change in Account Payables stood at $3909.0 in 2021, then plummeted by 74.24% to $1007.0 in 2022, then crashed by 332.67% to -$2343.0 in 2023, then soared by 90.57% to -$221.0 in 2024, then tumbled by 1660.63% to -$3891.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$3891.0, -$6471.0, and $221.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.